Alcohol inhalation

Por Le Foll, Bernard, Loheswaran, Genane
Publicado em 2014

Psychosocial and pharmacological interventions for the treatment of cannabis use disorder

Por Sabioni, Pamela, Le Foll, Bernard
Publicado no F1000Res (2018)

Transcriptomic Characterization of the Human Habenula Highlights Drug Metabolism and the Neuroimmune System

Por Le Foll, Bernard, French, Leon
Publicado no Front Neurosci (2018)

Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review

Por Butler, Kevin, Le Foll, Bernard
Publicado no Front Psychiatry (2019)

Treatment of tobacco dependence: integrating recent progress into practice

Por Le Foll, Bernard, George, Tony P.
Publicado em 2007

Effects of nicotine in experimental animals and humans: an update on addictive properties

Por Le Foll, Bernard, Goldberg, Steven R.
Publicado em 2009

Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction: A contribution for the special issue ‘The Dopamine D3 Receptor from Pre-Clinical Studies to the T...

Por Le Foll, Bernard, Di Ciano, Patricia
Publicado no Eur Neuropsychopharmacol (2014)

Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder

Por Di Ciano, Patricia, Le Foll, Bernard
Publicado no PLoS One (2016)

A 35-year-old woman with low mood and concerns about her alcohol use

Por Samokhvalov, Andriy V., Le Foll, Bernard
Publicado no CMAJ (2017)

A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variat

Por Thiruchselvam, Thulasi, Malik, Saima, Le Foll, Bernard
Publicado no Am J Drug Alcohol Abuse (2016)

High Reinforcing Efficacy of Nicotine in Non-Human Primates

Por Le Foll, Bernard, Wertheim, Carrie, Goldberg, Steven R.
Publicado em 2007

Dopamine D4 Receptors in Psychostimulant Addiction

Por Di Ciano, Patricia, Grandy, David, Le Foll, Bernard
Publicado no Adv Pharmacol (2014)

Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats

Por Le Foll, Bernard, Wertheim, Carrie E., Goldberg, Steven R.
Publicado em 2008

The future of endocannabinoid-oriented clinical research after CB(1) antagonists

Por Le Foll, Bernard, Gorelick, David A., Goldberg, Steven R.
Publicado em 2009

Pharmacotherapies for cannabis dependence

Por Marshall, Kushani, Gowing, Linda, Ali, Robert, Le Foll, Bernard
Publicado no Cochrane Database Syst Rev (2014)

Screening and Treatment for Alcohol, Tobacco and Opioid Use Disorders: A Survey of Family Physicians across Ontario

Por Loheswaran, Genane, Soklaridis, Sophie, Selby, Peter, Le Foll, Bernard
Publicado no PLoS One (2015)

Pharmacotherapies for cannabis dependence

Por Nielsen, Suzanne, Gowing, Linda, Sabioni, Pamela, Le Foll, Bernard
Publicado no Cochrane Database Syst Rev (2019)

QUELS FUTURS TRAITEMENTS POUR LA DEPENDANCE AU TABAC ET AU CANNABIS?

Por LE FOLL, Bernard, JUSTINOVA, Zuzana, TANDA, Gianlugi, GOLDBERG, Steven R.
Publicado em 2008

The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake

Por Gamaleddin, Islam, Guranda, Mihail, Goldberg, Steven R, Le Foll, Bernard
Publicado em 2011

BLOCKING CANNABINOID CB(1) RECEPTORS FOR THE TREATMENT OF NICOTINE DEPENDENCE: INSIGHTS FROM PRECLINICAL AND CLINICAL STUDIES

Por Le Foll, Bernard, Forget, Benoit, Aubin, Henri-Jean, Goldberg, Steven R.
Publicado em 2008